An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)

A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)

NCT00092859 ·Status: COMPLETED ·Phase: PHASE3

An Investigational Drug Study to Assess Weight Loss in Patients With Type 2 Diabetes Mellitus (0364-011)(TERMINATED)

NCT00430742 ·Status: TERMINATED ·Phase: PHASE3

A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)

NCT00533598 ·Status: COMPLETED ·Phase: PHASE2

A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity

NCT06662383 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Weight Maintenance Study in Obese Patients (0364-012)(TERMINATED)

NCT00420589 ·Status: TERMINATED ·Phase: PHASE3

To Study Different Levels of MK0493 for Safety, Efficacy, and Tolerability in Obese Patients (0493-017)(COMPLETED)

NCT00482196 ·Status: COMPLETED ·Phase: PHASE2

A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)

NCT00092872 ·Status: COMPLETED ·Phase: PHASE3

Individualized Obesity Pharmacotherapy

NCT03374956 ·Status: COMPLETED ·Phase: PHASE3

Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting

NCT02963935 ·Status: COMPLETED ·Phase: PHASE3

A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease

NCT04844918 ·Status: COMPLETED ·Phase: PHASE3

A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity

NCT06859268 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity

NCT06577766 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Study of Safety, Tolerability and Efficacy of MK0493 in Obese Patients (0493-008)(COMPLETED)

NCT00482638 ·Status: COMPLETED ·Phase: PHASE2

A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

NCT06525935 ·Status: COMPLETED ·Phase: PHASE2

Safety, Toleration and Efficacy of CP-741,952 for the Treatment of Obesity

NCT00367783 ·Status: TERMINATED ·Phase: PHASE2

A Study of LY3841136 in Overweight and Obese Participants

NCT06345066 ·Status: COMPLETED ·Phase: PHASE1

A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity

NCT06373146 ·Status: COMPLETED ·Phase: PHASE2

Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity

NCT03661879 ·Status: COMPLETED ·Phase: PHASE1

A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee

NCT05931367 ·Status: COMPLETED ·Phase: PHASE3

Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.

NCT00396448 ·Status: TERMINATED ·Phase: PHASE3

Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese

NCT06732245 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight

NCT07232719 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

NCT06143956 ·Status: RECRUITING ·Phase: PHASE2

A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese

NCT03600480 ·Status: COMPLETED ·Phase: PHASE1

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

NCT07035093 ·Status: RECRUITING ·Phase: PHASE3